Abstract
Investigator Initiated Clinical Trial of Valganciclovir, An Antiviral Drug for Symptomatic Congenital Cytomegalovirus Disease, Started at Nihon University Itabashi Hospital
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have